Alison Templeton Selected Research

cilgavimab

9/2023	Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial.
1/2023	AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.
10/2022	Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
1/2022	Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison Templeton Research Topics

Disease

5	COVID-19 12/2023 - 01/2022
2	Disease Progression 10/2022 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2019
1	Infections 01/2023
1	Cough 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 07/2005

Drug/Important Bio-Agent (IBA)

4	cilgavimab and tixagevimab drug combinationIBA 12/2023 - 01/2022
4	tixagevimabIBA 09/2023 - 01/2022
4	cilgavimabIBA 09/2023 - 01/2022
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 01/2019
2	NemiralisibIBA 01/2021 - 01/2019
1	Neutralizing AntibodiesIBA 12/2023
1	Monoclonal AntibodiesIBA 10/2022
1	AntigensIBA 10/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Pemetrexed (MTA)FDA Link 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	PlatinumIBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	osimertinibIBA 01/2017
1	Cholinergic AgonistsIBA 07/2005
1	Bethanechol (Duvoid)FDA LinkGeneric 07/2005

Therapy/Procedure

1	Intramuscular Injections 01/2023
1	Therapeutics 01/2017